Masimo (MASI) Short-term Investments (2010 - 2020)
Masimo's (MASI) quarterly Short-term Investments came in at $50.0 million in Q3 2020, down 58.33% year-on-year from $120.0 million in Q3 2019, and little changed quarter-over-quarter from $50.0 million in Q2 2020.
Masimo (MASI) Short-term Investments (2010 - 2020) Analysis & Trends
Masimo's Short-term Investments history runs 3 years deep, the most recent figure standing at $50.0 million for Q3 2020.
- On a quarterly basis, Short-term Investments fell 58.33% year-over-year to $50.0 million in Q3 2020; TTM through Sep 2020 was $50.0 million, a 58.33% decrease from a year earlier, with the FY2019 full-year figure at $120.0 million, changed N/A from the prior year.
- Short-term Investments steadied at $50.0 million in Q3 2020 per MASI's latest filing, from $50.0 million in the prior quarter.
- Across five years, Short-term Investments topped out at $180.0 million in Q1 2019 and bottomed at $50.0 million in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 26, 2020 | 50.00 Mn |
| Jun 27, 2020 | 50.00 Mn |
| Mar 28, 2020 | 50.00 Mn |
| Dec 28, 2019 | 120.00 Mn |
| Sep 28, 2019 | 120.00 Mn |
| Jun 29, 2019 | 180.00 Mn |
| Mar 30, 2019 | 180.00 Mn |
| Jan 2, 2010 | 56.99 Mn |